12 October 2016
The Metro UK reports
A government regulator has said that a cannabis chemical has a ‘restoring’ effect on humans – and is a legitimate medicine.
It could be a breakthrough moment for the movement to legalise cannabis in the UK, activists have said.
The MHRA (Medicines and Healthcare Products Regulation Agency) says that cannabidiol has a ‘restoring, correcting or modifying’ effect on ‘physiological functions’.
‘Cannabidiol’ (CBD), is a chemical from cannabis which campaigners claim helps with diseases including cancer and Crohn’s disease.
Crucially, CBD products don’t contain any THC, the chemical in cannabis which causes the high.
Jordan Owen, Managing Director of CBD company MediPen says, ‘Since our inception we’ve worked hard to obtain our goal of breaking down the negative connotations surrounding Cannabis to lead to a reform in the law for medicinal use.
‘This is now finally becoming a reality, which will lead to ground breaking results and provide those in need with legal access through a properly regulated UK market.’
‘As the UK’s leading consumer cannabis biotechnology company, we have been working very closely with MHRA classifiers over the past year and a half and have been deeply involved with all developments regarding the medicinal regulatory status of CBD. It was in fact, our legal team who initially pointed out that there was originally no regulatory status – causing the CBD industry in the UK to flourish without any premature intervention.’
Medicines & Healthcare Products Regulatory Agency
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health.